Hydralazine — $0 on Listed Strengths
Hydralazine is $0 on listed strengths only. Other strengths are not a blanket $0.
Hydralazine Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | $0 on listed strengths |
| Typical Retail | $52.00 |
$0 on listed strengths: 100mg Tablets (max 180); 10mg Tablets (max 270); 25mg Tablets (max 180); 50mg Tablets (max 180)
About Hydralazine
Hydralazine is a prescription medication. Ask your doctor if Hydralazine is right for you.
How to Check Hydralazine Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Hydralazine at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Heart & Cardiovascular
About Hydralazine
Hydralazine is a vital prescription medication often used to manage high blood pressure. For many, the ongoing cost of essential medications like hydralazine can be a significant burden. TheDrugClub is dedicated to making crucial prescriptions accessible and affordable, ensuring our members can get the care they need without financial stress.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Hydralazine is approved for (FDA label)
Severe essential hypertension when the drug cannot be given orally or when there is an urgent need to lower blood pressure.
Source: Read the full FDA label on DailyMed. Label effective date: August 14, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Hydralazine (FDA label)
To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Adverse reactions with hydralazine hydrochloride are usually reversible when dosage is reduced. However, in some cases it may be necessary to discontinue the drug. The following adverse reactions have been observed, but there has not been enough systematic collection of data to support an estimate of their frequency. Common: Headache, anorexia, nausea, vomiting, diarrhea, palpitations, tachycardia, angina pectoris. Less Frequent: Digestive -constipation, paralytic ileus. Cardiovascular -hypotension, paradoxical pressor response, edema. Respiratory -dyspnea. Neurologic -peripheral neuritis, evidenced by paresthesia, numbness, and tingling; dizziness; tremors; muscle cramps, psychotic reactions characterized by depression, disorientation, or anxiety. Genitourinary -difficulty in urination.
Source: FDA prescribing information (DailyMed). Set ID: dca82025-a4cd-4856-aa19-bdf091bf8973. SPL document ID: 5905ae5e-7ec3-d680-e063-6294a90aa154. Label effective date: August 14, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Hydralazine (FDA label)
Hypersensitivity to hydralazine, coronary artery disease, mitral valvular rheumatic heart disease.
Source: FDA prescribing information (DailyMed). Set ID: dca82025-a4cd-4856-aa19-bdf091bf8973. SPL document ID: 5905ae5e-7ec3-d680-e063-6294a90aa154. Label effective date: August 14, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Hydralazine (FDA label)
MAO inhibitors should be used with caution in patients receiving hydralazine. When other potent parenteral antihypertensive drugs, such as diazoxide, are used in combination with hydralazine, patients should be continuously observed for several hours for any excessive fall in blood pressure. Profound hypotensive episodes may occur when diazoxide injection and hydralazine hydrochloride injection are used concomitantly.
Source: FDA prescribing information (DailyMed). Set ID: dca82025-a4cd-4856-aa19-bdf091bf8973. SPL document ID: 5905ae5e-7ec3-d680-e063-6294a90aa154. Label effective date: August 14, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.